Zobrazeno 1 - 10
of 608
pro vyhledávání: '"Hht"'
Autor:
Eliza Tuff-Gordon, Marie E. Faughnan, Helen Kim, Michael T. Lawton, Nicholas T. Vozoris, the Brain Vascular Malformation Consortium HHT Investigator Group, Murali Chakinala
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/4a9ff804185843deadb4dcb4b9cd8730
Autor:
Jillian L. Cardinell, Joel M. Ramjist, Chaoliang Chen, Weisong Shi, Nhu Q. Nguyen, Tiffany Yeretsian, Matthew Choi, David Chen, Dewi S. Clark, Anne Curtis, Helen Kim, Marie E. Faughnan, Victor X. D. Yang, the Brain Vascular Malformation Consortium HHT Investigator Group
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder that causes vascular malformations throughout the body. The most prevalent and accessible of these lesions are found throughout the skin and mucosa, and often rupt
Externí odkaz:
https://doaj.org/article/c250c6272eb94a2cb116b4cce7039970
Publikováno v:
Advances in Medical Education and Practice, Vol Volume 12, Pp 1477-1486 (2021)
Thinh H Nguyen,1,* Truc T Thai,2,* Phuong TT Pham,2 Tam NM Bui,1 Han HT Bui,3 Bac Hoang Nguyen1 1Training and Scientific Research Department, University Medical Center Ho Chi Minh City, Ho Chi Minh City, Vietnam; 2Faculty of Public Health, Un
Externí odkaz:
https://doaj.org/article/cb7e97aeb2494caa99198e17e817254c
Publikováno v:
Psychology Research and Behavior Management, Vol Volume 14, Pp 1915-1927 (2021)
Truc Thanh Thai,1 Mairwen K Jones,2 Thao Phuong Nguyen,1 Thao Van Pham,1 Han Hy Thi Bui,3 Loan Xuan Kim,1 Tap Van Nguyen4 1Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City Vietnam; 2Faculty of Medici
Externí odkaz:
https://doaj.org/article/326fd9f12f4b49d2a66ac910a8ca8e3d
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 14, Pp 4281-4291 (2021)
Truc Thanh Thai,1 Thinh Huu Nguyen,2 Phuong Thu Thi Pham,3 Han Hy Thi Bui,4 Tam Ngoc Minh Bui2 1Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam; 2Training and Scientific Research Department
Externí odkaz:
https://doaj.org/article/e3352cca01c24bc1a3cc405f6b4c2d05
Autor:
K. P. Thompson, J. Nelson, H. Kim, S. M. Weinsheimer, D. A. Marchuk, M. T. Lawton, T. Krings, M. E. Faughnan, Brain Vascular Malformation Consortium HHT Investigator Group
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-7 (2021)
Abstract Background Approximately 10% of hereditary hemorrhagic telangiectasia (HHT) patients harbour brain vascular malformations (VMs). Intracranial hemorrhage (ICH) from brain VMs can lead to death or morbidity, while treatment options for brain V
Externí odkaz:
https://doaj.org/article/77e8d90e8c0e4c73afa7b8b9cc4b5ae5
Autor:
K. P. Thompson, J. Nelson, H. Kim, L. Pawlikowska, D. A. Marchuk, M. T. Lawton, Marie E. Faughnan, the Brain Vascular Malformation Consortium HHT Investigator Group
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background Retrospective questionnaire and healthcare administrative data suggest reduced life expectancy in untreated hereditary hemorrhagic telangiectasia (HHT). Prospective data suggests similar mortality, to the general population, in De
Externí odkaz:
https://doaj.org/article/3d79a611241d4508a3f9ca866a6886cd
Autor:
Beslow, Lauren A., Vossough, Arastoo, Kim, Helen, Nelson, Jeffrey, Lawton, Michael T., Pollak, Jeffrey, Lin, Doris D. M., Ratjen, Felix, Hammill, Adrienne M., Hetts, Steven W., Gossage, James R., Whitehead, Kevin J., Faughnan, Marie E., Krings, Timo, Brain Vascular Malformation Consortium HHT Investigator Group, Atherton, Mary E., Chakinala, Murali M., Clancy, Marianne S., Henderson, Katharine, Hetts, Steven
Publikováno v:
Child's Nervous System; Jul2024, Vol. 40 Issue 7, p2101-2108, 8p
Autor:
Eleonora Gaetani, Fabiana Agostini, Angelo Porfidia, Igor Giarretta, Daniela Feliciani, Luigi Di Martino, Annalisa Tortora, Antonio Gasbarrini, Roberto Pola, on behalf of the Multidisciplinary Gemelli Group for HHT
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-5 (2019)
Abstract Subjects with the rare autosomal dominant disease Hereditary Hemorrhagic Telangiectasia (HHT) may develop medical conditions that require antithrombotic therapy (AT). However, safety of AT is uncertain in these patients and the only data cur
Externí odkaz:
https://doaj.org/article/6dba041cfebd430ca58ab39d2040743d
Autor:
C. L. Shovlin, C. M. Millar, F. Droege, A. Kjeldsen, G. Manfredi, P. Suppressa, S. Ugolini, N. Coote, A. D. Fialla, U. Geisthoff, G. M. Lenato, H. J. Mager, F. Pagella, M. C. Post, C. Sabbà, U. Sure, P. M. Torring, S. Dupuis-Girod, E. Buscarini, VASCERN-HHT
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-8 (2019)
Abstract Background Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular dysplasia resulting in visceral arteriovenous malformations and smaller mucocutaneous telangiectasia. Most patients experience recurrent nosebleeds and become anemic w
Externí odkaz:
https://doaj.org/article/d71578396d96461388812ee10de55b6b